Germany's Merck wants more than just Millipore (MIL). After agreeing to buy the biotech tool...

|By:, SA News Editor

Germany's Merck wants more than just Millipore (MIL). After agreeing to buy the biotech tool maker for $6B in cash, Merck CEO Karl-Ludwig Kley says "acquisitions are a part of our strategy," and that the company already has a few new takeover ideas.